Provided by Tiger Trade Technology Pte. Ltd.

LIFECORE BIOMEDICAL INC

6.52
-0.0200-0.31%
Post-market: 6.520.00000.00%19:30 EDT
Volume:840.59K
Turnover:5.48M
Market Cap:246.80M
PE:-7.04
High:6.57
Open:6.54
Low:6.51
Close:6.54
52wk High:8.98
52wk Low:3.63
Shares:37.85M
Float Shares:19.33M
Volume Ratio:0.61
T/O Rate:4.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9257
EPS(LYR):-0.5400
ROE:-76.41%
ROA:-3.04%
PB:-17.38
PE(LYR):-12.07

Loading ...

Barrington Adjusts Price Target on Lifecore Biomedical to $6.50 From $6, Maintains Outperform Rating

MT Newswires Live
·
Jun 16

Lifecore price target raised to $6.50 from $6 at Barrington

TIPRANKS
·
Jun 16

Lifecore Biomedical Signs Deal to Support Manufacturing of Neurology Injection Product

MT Newswires Live
·
Jun 15

Lifecore Biomedical signs tech transfer, commercial manufacturing deal for marketed neurology injectable suspension

Reuters
·
Jun 15

Lifecore Biomedical Signs New Agreement With Global Pharmaceutical Company

THOMSON REUTERS
·
Jun 15

Lifecore Biomedical Signs New Agreement with Global Pharmaceutical Company

GlobeNewswire
·
Jun 15

Lifecore Biomedical Signs Manufacturing Services Agreement With Ophthalmic Customer

MT Newswires Live
·
Jun 02

Lifecore Biomedical signs manufacturing services deal with new ophthalmic customer

Reuters
·
Jun 02

Lifecore Biomedical Signs Agreement With New Biopharmaceutical Customer

THOMSON REUTERS
·
Jun 02

Lifecore Biomedical attends William Blair Growth Stock Conference

Reuters
·
May 21

Lifecore Biomedical attends CDMO Live Europe, joins tech transfer panel

Reuters
·
May 13

Lifecore reports Q1 EPS (43c), consensus (29c)

TIPRANKS
·
May 07

Lifecore Biomedical Q1 revenue falls 34%, misses analyst estimates

Reuters
·
May 06

BRIEF-Lifecore Biomedical Q1 Revenue USD 23.2 Million

Reuters
·
May 06

Lifecore Biomedical Inc - Reaffirms 2026 Revenue and Adj Ebitda Guidance

THOMSON REUTERS
·
May 06

Lifecore Biomedical Reports Financial Results for the First Quarter Ended March 31, 2026, and Provides Corporate Update

GlobeNewswire
·
May 06

Lifecore Biomedical Inc expected to post a loss of 24 cents a share - Earnings Preview

Reuters
·
May 04

Lifecore Biomedical Is Maintained at Outperform by Barrington Research

Dow Jones
·
Apr 30

Lifecore Biomedical to report first-quarter results, host webcast

Reuters
·
Apr 30

Barrington Raises Price Target on Lifecore Biomedical to $6 From $5.50, Keeps Outperform Rating

MT Newswires Live
·
Apr 29